The present invention relates to altered antibodies to myelin associated glycoprotein (MAG), pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.

 
Web www.patentalert.com

< Method for treating kidney disorders

> Wound alternative treatment system

> Process for providing antimicrobial surfaces

~ 00556